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and Patricia A. Conrad*
Campylobacter and Salmonella spp. prevalence and
antimicrobial drug sensitivity were determined in northern
elephant seals that had not entered the water and seals that
were stranded on the California coast. Stranded seals had a
higher prevalence of pathogenic bacteria, possibly from ter-
restrial sources, which were more likely to be resistant.
Alimited number of surveys have shown that pinnipeds(seals, sea lions, and walruses) can be infected with
zoonotic enteric bacteria, including Salmonella and
Campylobacter spp. and that some strains are resistant to
antimicrobial drugs (1–3). Because both Salmonella and
Campylobacter spp. are important zoonotic organisms,
their presence in marine mammal feces raises concerns
regarding risks to human health associated with exposure
to coastal waters and marine mammals. Another concern is
that these bacteria in marine mammals may reflect pollu-
tion of the California coast by feces from terrestrial
sources, including sewage and runoff that contain domes-
tic animal waste. To address these concerns, more detailed
data on bacterial pathogen distribution along the California
coast are needed.
Northern elephant seals (Mirounga angustirostris) are
born on various California beaches and do not leave the
beaches for several months after birth (4). Once the seals
leave their natal beaches, they are at sea for most of their
lives other than during breeding and the annual molt or if
they are found “stranded” (if poor health or injury prevents
them from leaving the shore) (5). We investigated the
prevalence and antimicrobial drug sensitivity of
Salmonella and Campylobacter spp. in northern elephant
seals at different sites in California to ascertain the distri-
bution of these bacteria in pinnipeds and determine their
potential effect on marine mammal and human health.
The Study
In February and March of 2003 and 2004, 165 northern
elephant seals, which had been recently weaned and had
never entered the water, were sampled on their natal
beaches at 3 colonies in California (Figure). From
February to July in 2003 and 2004, 195 juvenile northern
elephant seals were found stranded live along the
California coast, rescued, and brought to The Marine
Mammal Center (TMMC), Sausalito, California, for reha-
bilitation. At TMMC, seals were physically restrained and
examined, and rectal swabs with Cary-Blair transport
medium (BD Diagnostics, Franklin Lakes, NJ, USA) were
collected for bacterial culture. Animals were not treated
until after sampling.
Salmonella enterica was isolated, identified with stan-
dard procedures (6), and stored at –80°C in Microbank
bead vials (Pro-Lab Diagnostics, Austin, TX, USA) until it
was tested for antimicrobial drug susceptibility.
Salmonella isolates were sent to the National Veterinary
Services Laboratory (Ames, IA, USA) for serotyping.
Antimicrobial drug susceptibility was performed with
broth microdilution according to the Sensititre user manu-
al and National Committee for Clinical Laboratory
Standards (NCCLS) guidelines (7) for amikacin, amoxi-
cillin-clavulanic acid, ampicillin, cefazolin, ceftiofur, cef-
tizoxime, chloramphenicol, enrofloxacin, gentamicin,
tetracycline, ticarcillin-clavulanic acid, and trimethoprim-
sulfamethoxazole. Campylobacter spp. were selected by
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Figure. Location of The Marine Mammal Center (TMMC), rescue
range of TMMC (shaded), and northern elephant seal rookeries
(Point Reyes National Seashore, Point Año Nuevo, Piedras
Blancas) where seals were sampled along the California coastline.
using Campy-CVA agar (Hardy Diagnostics, Santa Maria,
CA, USA) that was incubated under microaerophilic con-
ditions at 37°C for 48 to 96 h, identified by using standard
procedures (8), and stored at –80°C in Microbank bead
vials until they were tested for antimicrobial drug suscep-
tibility. Campylobacter isolates were tested for susceptibil-
ity to ciprofloxacin, doxycycline, erythromycin, and
gentamicin according to previously described techniques
(9,10). Odds ratios were compared among the different
bacteria and seal populations by using mixed- or fixed-
effects logistic regression, with geographic location as the
random effect and seal rookery as the fixed effect (11). A
forward-stepping algorithm was used, and terms with
p<0.05, based on the Wald statistic, were included in the
final model. 
Salmonella spp. were isolated from 3 (1.8%) of 165
natal-site elephant seals and 72 (36.9%) of 195 stranded
seals. Stranded seals were 41× more likely to test positive
for Salmonella spp. than natal-site seals (odds ratio [OR]
40.9, p<0.001, 95% confidence interval [CI] 7.7–218). All
3 Salmonella isolates from the natal-site seals were
serotype Typhimurium and were sensitive to all antimicro-
bial drugs tested (Table 1). Eighty-three Salmonella iso-
lates of 5 different serotypes, Newport, Saint Paul,
Montevideo, Typhimurium, and Reading, were collected
from 72 stranded seals; Newport was the most common
serotype. Eleven stranded seals were positive for 2 differ-
ent serotypes. Only 4 Salmonella Newport isolates from
stranded seals were resistant to antimicrobial drugs; 3 iso-
lates were resistant to ampicillin, with intermediate resist-
ance to ticarcillin-clavulanic acid, and 1 isolate was
resistant to amoxicillin–clavulanic acid and cefazolin.
On the basis of biochemical analysis, Campylobacter
jejuni, C. lari, and an unknown Campylobacter sp. were
isolated from both groups of elephant seals (Table 2). C.
jejuni was the most common Campylobacter species isolat-
ed, followed by C. lari and the unknown Campylobacter sp.
(Table 2). One natal-site seal and 8 stranded seals were
infected with 2 Campylobacter spp. Stranded seals were
6.0× more likely to test positive for Campylobacter spp.
than natal-site seals (OR 5.97, p<0.001, 95% CI 4.2–8.4).
Stranded seals were 4.3× more likely to be positive for C.
jejuni (OR 4.33, p<0.001, 95% CI 1.8–10.6), 7.2× more
likely to be positive for C. lari (OR 7.2, p<0.001, 95% CI
2.4–21.4), and 22× more likely to be positive for the
unknown Campylobacter sp. (OR 21.9, p = 0.003, 95% CI
2.9–164) than natal-site seals. Ciprofloxacin was the only
antimicrobial drug to which isolates were resistant (interme-
diate or complete); resistance was detected in both groups
of seals but was more common in stranded seals (Table 2).
Conclusions
Prevalence of Salmonella and Campylobacter spp. was
higher in juvenile northern elephant seals that became
stranded along the coast of central California than in seals
on their natal beaches that had never entered the water. A
potential explanation for this difference is that stranded
seals may have harbored bacteria but were not shedding
them while they were in good health on their natal beach-
es. Infections with some pathogenic bacteria may be
asymptomatic, but animals may intermittently shed bacte-
ria, especially if stressed (12,13). Stress and malnutrition
can suppress immunity, which makes an individual animal
more susceptible to infection and prolongs existing infec-
tion (14). Another possible explanation for the higher
prevalence in stranded seals is that stranded animals are
more susceptible to infection, because of stress or malnu-
trition, by pathogens in the environment from terrestrial
sources, such as contaminated freshwater and sewage out-
fall. The fact that isolates from stranded seals tend to be
resistant supports this possibility.
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The cause of the higher prevalence of pathogenic bac-
teria in stranded juvenile northern elephant seals should be
determined, especially if animals are infected by pathogen-
ic bacteria from terrestrial sources contaminating the
marine environment. Coastal freshwater runoff is associat-
ed with a high risk for infection of southern sea otters
(Enhydra lutris nereis) with Toxoplasma gondii in
California and might also be a risk factor for infection of
elephant seals with pathogenic fecal bacteria (15). Further
studies to identify environmental risk factors for infection
of elephant seals with Campylobacter and Salmonella spp.
and genetic fingerprinting of these isolates may help deter-
mine the sources of these bacteria.
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